May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Inhibitory Effect of YC–1 on Experimental Choroidal Neovascularization in Rat
Author Affiliations & Notes
  • S.–J. Song
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • K. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • Y. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • J.–M. Seo
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • K. Park
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
    Bundang Seoul National University Hospital, Sungnam, Republic of Korea
  • S. Kim
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • H. Chung
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • H. Yu
    Ophthalmology, Seoul National University School of Medicine, Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  S. Song, None; K. Kim, None; Y. Kim, None; J. Seo, None; K. Park, None; S. Kim, None; H. Chung, None; H. Yu, None.
  • Footnotes
    Support  Korea Health 21 R&D Project MOHW 02–PJ1–PG1–CH02–0003
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1418. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.–J. Song, K. Kim, Y. Kim, J.–M. Seo, K. Park, S. Kim, H. Chung, H. Yu; Inhibitory Effect of YC–1 on Experimental Choroidal Neovascularization in Rat . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1418.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effects of YC–1[3–(5'–hydroxymethyl–2'–furyl)–1–benzylindazole], one of the hypoxia–inducible factor–1 (HIF –1) inhibitor, on laser–induced choroidal neovascularization (CNV) in rats. Methods: Thirty female Brown–Norway rats underwent laser photocoagulation to induce CNV, and then twenty rats were treated with intraperitoneal YC–1 (3mg/kg) for two weeks. For controls, ten rats were sham–treated with DMSO. Fundus photography and fluorescein angiography were performed at 2, 3, and 4 weeks after laser.The expression of HIF–1 and VEGF at CNV was evaluated with immunohistochemistry. The size of the CNV was histologically quantified. Results: The expressions of both HIF–1 and VEGF were increased at the photocoagulation–induced CNV, but decreased in rats treated with YC–1. Treatment with YC–1 decreased the size of CNV by 60 %, compared to controls. No systemic toxicity of YC–1 was found in this study. Conclusions: These results suggest that YC–1 suppresses the development of experimental CNV by inhibiting the HIF–1 expression at the photocoagulation site.

Keywords: choroid: neovascularization • drug toxicity/drug effects • microscopy: light/fluorescence/immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×